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ABSTRACT
Animal cloning has been achieved in many species by transplanting
differentiated cell nuclei to unfertilized oocytes. However, the low
efficiencies of cloning have remained an unresolved issue. Here we
find that the combination of two small molecules, trichostatin A (TSA)
and vitamin C (VC), under culture condition with bovine serum
albumin deionized by ion-exchange resins, dramatically improves the
cloning efficiency in mice and 15% of cloned embryos develop to
term by means of somatic cell nuclear transfer (SCNT). The
improvement was not observed by adding the non-treated, rather
than deionized, bovine serum. RNA-seq analyses of SCNT embryos
at the two-cell stage revealed that the treatment with TSA and VC
resulted in the upregulated expression of previously identified
reprogramming-resistant genes. Moreover, the expression of early-
embryo-specific retroelements was upregulated by the TSA and VC
treatment. The enhanced gene expression was relevant to the VC-
mediated reduction of histone H3 lysine 9 methylation in SCNT
embryos. Our study thus shows a simply applicable method to greatly
improve mouse cloning efficiency, and furthers our understanding
of how somatic nuclei acquire totipotency.
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INTRODUCTION
Nuclear reprogramming of a differentiated into undifferentiated
embryonic cell state was originally demonstrated by the transfer of
somatic cell nuclei into unfertilized eggs using frogs (Gurdon,
1962). Later, successfully cloned animals were reported in many
mammalian species using similar strategies (Wakayama et al., 1998;
Wilmut et al., 1997). These reprogramming technologies have been
greatly accelerated by the finding of induced pluripotent stem (iPS)
cells (Takahashi and Yamanaka, 2006). iPS cells are currently
regarded as the most convincing source for regenerative medicine
while mounting evidence suggests that somatic cell nuclear transfer
(SCNT) into enucleated oocytes can result in embryonic stem cells
with high quality from the cloned blastocysts (Kim et al., 2010; Ma
et al., 2014; Tachibana et al., 2013). Moreover, nuclear transfer
techniques offer unique opportunities to revive animals from frozen
tissues, potentially including extinct animals (Folch et al., 2009;
Wakayama et al., 2008), to produce transgenic animals from
somatic cells and to propagate animals with beneficial traits.
However, many of these promising attempts have been impeded by
the low success rates of SCNT.
Tremendous efforts have been made to improve cloning
efficiency. Since failures of epigenetic reprogramming have been
often reported in cloned embryos during preimplantation
development (Teperek and Miyamoto, 2013), small molecules to
alter histone modifications are widely used to facilitate development
of SCNT embryos (Ogura et al., 2013). The addition of trichostatin
A (TSA), a histone deacetylase inhibitor, to culture medium of
SCNT embryos for appropriate duration improves mouse cloning
from less than 1% to 6.5% (Kishigami et al., 2006; Rybouchkin
et al., 2006). TSA treatment increases levels of histone acetylation
and reduces those of repressive histone methylation (Bui et al.,
2010), which presumably results in correcting the aberrant
expression of transcription factor genes in cloned two-cell
embryos (Inoue et al., 2015). Recently, substantial improvements
in mouse cloning have been shown by enzymatically removing
repressive histone H3 lysine 9 trimethylation (H3K9me3) and up to
11% of SCNT embryos develop to term (Liu et al., 2016; Matoba
et al., 2014). This is also true in the case of human somatic cell
nuclear transfer (Chung et al., 2015). It is therefore desirable to
develop a simple method to lower the level of H3K9me3 in SCNT
embryos, for example by supplementation of small molecules to
culture medium (Huang et al., 2016) in order to achieve dramatic
improvement in animal cloning.
The effect of vitamin C (VC) on the reduction of histone H3K9
methylation and DNA methylation has been well documented in
embryonic stem (ES) and iPS cells (Blaschke et al., 2013; Chen
et al., 2013; Hore et al., 2016; Walter et al., 2016). VC mediates
reduction of Fe3+ to Fe2+ (Hore et al., 2016), accelerating DNA and
histone demethylation through the enhanced activity of Fe2+- and
oxoglutarate-dependent enzymes (Monfort and Wutz, 2013). This
role of VC as a potent epigenetic modifier, in addition to the well-
characterized antioxidant role, allows enhanced reprogramming in
iPS cells (Chen et al., 2013; Esteban et al., 2010; Stadtfeld et al.,
2012; Wang et al., 2011). Reprogramming after SCNT is also aided
by VC supplementation to embryo culture medium in mice (Mallol
et al., 2015) and pig (Huang et al., 2011), although improvements in
birth rates of cloned mice are modest compared to mRNA injection
of histone modifiers (up to 5% versus 11%, respectively). The extent
of epigenetic reprogramming and changes in gene expression needReceived 2 December 2016; Accepted 15 February 2017
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to be determined in VC-treated SCNT embryos. Another important
aspect that has not been well explored is whether VC further
enhances its effect on reprogramming in collaboration with other
factors.
In this report, we examined synergistic effects of TSA and VC, two
well-known epigenetic modifiers that can enhance reprogramming.
We find that TSA and VC facilitate reprogramming at different times
during the one-cell stage and, moreover, synergistically work for the
development of SCNT embryos. Interestingly, the effect of TSA and
VC is best exerted in our embryo culture condition containing
deionized bovine serum albumin (dBSA) (Isaji et al., 2015), resulting
in 15% of cloning efficiency.Mechanistically, expression of transcripts
that are normally downregulated in cloned embryos is rescued by the
sequential treatment of TSA andVCwith dBSA.Our improved culture
condition allows stable production of cloned mice, thus enabling the
SCNT technology to be used for a variety of purposes.
RESULTS
The sequential treatment of trichostatin A and vitamin C
boosts cloning efficiency in mice
TSA has been shown to enhance the development of SCNT
embryos when it is added to the medium for 10 h or less after egg
activation, whereas longer exposure to TSA diminished enhanced
embryonic development (Kishigami et al., 2006). We therefore
hypothesized that treatment with VC also has a time window when
its positive effects are maximized. As a first step, we tested the effect
of different concentrations of VC on preimplantation development
of mouse SCNT embryos using cumulus cells as donors. VC was
supplemented in the embryo culture medium for 24 h after egg
activation. Development to the blastocyst stage was significantly
improved when 10 μg/ml or more of VC was supplemented
(Fig. 1A). We then examined the number of cells at the blastocyst
stage. Among the three different concentrations that enhanced
development (10, 25 and 50 μg/ml; Fig. 1A), blastocysts treated
with 10 μg/ml of VC exhibited a significantly higher number of
inner cell mass and trophectoderm cells than control blastocysts
(Fig. 1B; P<0.05). These results indicate that 10 μg/ml of VC
enhances preimplantation development of mouse SCNT embryos.
We next examined an appropriate timing of VC treatment for SCNT
embryos. It has been reported that 15 h incubation with VC is
enough to enhance the development of cloned embryos in pigs
(Huang et al., 2011). We further split 15 h of treatment to 8 and 7 h
[VC(0-8 h) and VC(8-15 h), respectively]. Interestingly, VC(0-8 h)
did not enhance development to the blastocyst stage significantly,
while the preimplantation development was improved by VC(8-
15 h) (Fig. 1C). As previously reported, significant improvement
of embryonic development by TSA was observed when it was
added 0-8 h after premature chromosome condensation (Fig. 1C).
Together, VC enhances preimplantation development of mouse
SCNTembryos and its positive effect is observed when VC is added
8-15 h after egg activation, which represents a different timing from
that of TSA treatment.
The optimization experiments of VC treatment for the
development of SCNT embryos show that VC works at a different
timing to TSA. We therefore hypothesized that the combinational
treatment with TSA and VC might further enhance development of
SCNT embryos. The sequential treatment with TSA and VC
supported highly efficient in vitro development to the blastocyst
stage [TSA(0-8 h)+VC(8-15 h); Fig. 1C]. Enhanced development
was also observed using embryonic fibroblast cells derived from
ICR×ICR mice (27% versus 71%; Fig. 1D), demonstrating that the
positive effect of TSA and VC is neither limited by mouse strains
nor by cell types. We then evaluated in vivo development of SCNT
embryos with various controls using cumulus cells as donors
(Table 1). VC treatment itself improved the implantation rate when
SCNT embryos at the two-cell stage were transferred to surrogates
(Table 1). An even higher implantation rate was obtained when TSA
was supplemented before VC treatment [TSA(0-8 h)+VC(8-15 h);
Table 1]. Importantly, birth rates were dramatically improved
by TSA(0-8 h)+VC(8-15 h) treatment compared to all other
treatments, including only TSA or VC treatment, and 15% of the
transferred cloned embryos developed to live pups (Fig. 1E and
Table 1). High birth rates of cloned pups were reproduced by three
different operators in two different institutes (Fig. S1A,B). Cloned
fetuses obtained by TSA(0-8 h)+VC(8-15 h) treatment showed
similar body and placental weight to other treatments (Table 1).
These results indicate that TSA and VC synergistically work to
markedly improve the cloning efficiency in mice.
The effects of antioxidants and deionized BSA on
development of SCNT embryos
VC is known as an effective antioxidation reagent. We therefore
asked if other antioxidants similarly enhance the development of
mouse SCNT embryos. N-acetyl-L-cysteine (NAC) (Esteban et al.,
2010) or vitamin E (Esteban et al., 2010) was added to the culture
medium 8-15 h after the commencement of activation, which is the
same timing as when VC’s positive effect is observed. Although the
VC treatment enhanced the development of SCNT embryos, neither
NAC nor vitamin E improved the preimplantation development
of mouse SCNT embryos (Fig. S2A). These results suggest that VC
is not simply replaced by other antioxidants to enhance cloning
efficiency. The improved development by VC treatment might not
be through its antioxidant effects, although we cannot exclude some
contribution of antioxidation to development.
Our culture medium contains deionized bovine serum albumin
(dBSA), since commercially available BSA often involves trace
amounts of transitionmetal ions, such as Zn2+ and Cu2+, harmful for
preimplantation development (Vidal and Hidalgo, 1993). It is also
known that VC is reactive to metal ions (Carr and Frei, 1999). We
therefore tested if dBSA is crucial for the high developmental
potential of TSA- and VC-treated embryos. Development to the
blastocyst stage was impaired when BSA was supplemented in the
medium and donor cell suspension instead of dBSA (Fig. S2B,C),
suggesting that dBSA is also a critical factor for the improved
cloning efficiency.
Rescued gene expression in TSA- and VC-treated cloned
embryos at the two-cell stage
In order to understand the molecular basis of improved development
of TSA- and VC-treated cloned embryos, we performed RNA-seq
analyses. SCNT embryos at the two-cell stage (28 h after egg
activation), which is right after zygotic genome activation, were
used so that an immediate response of TSA(0-8 h)+VC(8-15 h)
treatment to gene activation can be judged, and because a previous
study identified abnormally expressed genes in SCNT embryos at
the same stage (Matoba et al., 2014). Single SCNT embryos
incubated in various conditions were subjected to RNA-seq
(Fig. 2A). Hierarchical clustering indicated that the transcriptomes
of SCNT embryos with TSA(0-8 h)+VC(8-15 h) treatment
resembled each other even though nuclear transfer was performed
in three independent experiments (Fig. 2B). Interestingly, the
treatment with TSA(0-8 h) also resulted in a reproducible
transcriptome, but it represented a significantly different pattern
from TSA(0-8 h)+VC(8-15 h) (blue box versus red box; Fig. 2B).
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Heat map analysis showed reproducibly upregulated gene
expression in SCNT embryos with TSA(0-8 h)+VC(8-15 h) (red
box; Fig. S3A), compared to other treatments. Indeed, TSA(0-8 h)+
VC(8-15 h)-treated SCNT embryos showed approximately two
times more upregulated transcripts than downregulated transcripts
when compared to control SCNT embryos (141 upregulated versus
63 downregulated transcripts, FDR<0.05; Fig. S3B and Table S1).
GO analysis indicated that different categories of genes were
found between up- and down-regulated transcripts (Fig. S3C).
Upregulated transcripts included genes involved in transcriptional
regulation and RNA processing (Fig. S3C), representing a similar
category to transcripts previously identified as abnormally
downregulated in cloned two-cell embryos (Matoba et al., 2014).
We then asked if the transcripts upregulated in TSA(0-8 h)+VC(8-
15 h) treatment contained the abnormally repressed genes in SCNT
embryos (Matoba et al., 2014). Hypergeometric tests indicated that
the abnormally downregulated genes were significantly enriched in
our upregulated gene list by TSA(0-8 h)+VC(8-15 h) (top venn
Fig. 1. The effect of epigeneticmodifiers, trichostatin A (TSA) and vitaminC (VC), on the development ofmouseSCNTembryos. (A) The effect of different
concentrations of VCon preimplantation development of the cloned embryos. VC at concentrations of 10 µg/ml andmore enhanced development to the blastocyst
stage. Different letters within the same stage indicate statistical significance (P<0.05, one-way ANOVA with subsequent Tukey’s multiple comparison tests).
Between 31 and 139 two-cell embryos were used in each treatment (each treatment: n=3-5, control VC 0 μg/ml: n=15). (B) Cell numbers of cloned blastocysts
after the treatment with VC at concentrations of 10 µg/ml andmore. Different letters within the same part indicate statistical significance (P<0.05). Between 12 and
31 blastocysts were examined (n=3-7). (C) Comparison of development to the blastocyst stage of the cloned embryos among VC treatment of different durations,
TSA treatment and serial treatment with TSA and VC. Cumulus cells derived from B6D2F1 mouse were used as donor cells. Actual numbers of embryos
developed to blastocysts per two-cell embryos are indicated above the corresponding graphs. Different letters indicate statistical significance (P<0.05; each
treatment: n=3-6, control: n=12). (D) Comparison of development to the blastocyst stage of the cloned embryos using embryonic fibroblasts derived from ICR×ICR
mice as donor cells between control non-treated embryos and serially treated embryoswith TSA andVC. Actual numbers of embryos developed to blastocysts per
two-cell embryos are indicated above the corresponding graphs. Different letters indicate statistical significance (P<0.05; n=4,6). (E) Five cloned fetuses and
placentae in one foster mother, which were produced by the serial treatment of TSA and VC.
417
RESEARCH ARTICLE Biology Open (2017) 6, 415-424 doi:10.1242/bio.023473
B
io
lo
g
y
O
p
en
diagram, P=9.3×10−13; Fig. 2C), indicating that TSA+VC treatment
at least partially rescues abnormal gene expression in SCNT
embryos. Hypergeometric tests were also carried out against histone
H3 lysine 9 trimethylation (H3K9me3)-enriched reprogramming-
resistant genes identified in the mouse SCNT experiment (Matoba
et al., 2014) and human iPS cells (Soufi et al., 2012).
Reprogramming-resistant regions found in Matoba et al. (2014)
contained 1767 genes, and 26 genes overlapped between those
H3K9me3-enriched genes in SCNT embryos and the genes
upregulated by TSA+VC (P=1.1×10−6; Fig. 2C; Table S2).
In contrast, H3K9me3-enriched reprogramming-resistant genes
identified in the iPS experiment did not show significant overlap
with our gene list (P=0.44; Fig. 2C). In conclusion, abnormal gene
expression of protein-coding genes, which is often observed in
SCNT embryos, is alleviated by serial treatment with TSA and VC
after nuclear transfer.
TSA and VC differentially, but cooperatively, contribute to
transcriptional activation in SCNT embryos at the two-cell
stage
In order to gain insight into the synergistic effects of TSA(0-8 h)+
VC(8-15 h), we sought to identify specific effects of TSA(0-8 h)+
VC(8-15 h) on gene expression in SCNT embryos at the two-cell
stage by comparing to other treatments such as TSA(0-8 h). In
contrast to TSA(0-8 h)+VC(8-15 h)-treated SCNT embryos as
described above (Table S1), TSA(0-8 h)-treated embryos showed
approximately two times more downregulated transcripts than
upregulated transcripts when compared to control SCNT embryos
(43 upregulated versus 97 downregulated transcripts, FDR<0.05;
Table S3); the detection of more downregulated transcripts is in
good agreement with the previous study that also identified
approximately two times more downregulated transcripts after the
TSA treatment (Inoue et al., 2015). Nevertheless, among 43
upregulated transcripts, 13 transcripts were also found in the
upregulated gene list in TSA(0-8 h)+VC(8-15 h)-treated embryos
(Table S1), suggesting that at least some, but not all, transcripts
upregulated by TSA(0-8 h)+VC(8-15 h) are due to the TSA
treatment. We then examined the effect of the VC treatment
by comparing TSA(0-8 h)-treated embryos to TSA(0-8 h)+VC
(8-15 h)-treated ones. TSA(0-8 h)+VC(8-15 h)-treated embryos
showed 3.7 times more upregulated transcripts than
downregulated transcripts when compared to TSA(0-8 h)-treated
embryos (153 upregulated versus 41 downregulated transcripts,
FDR<0.05; Table S4). GO analysis showed that genes related to
apoptosis were downregulated in TSA(0-8 h)+VC(8-15 h)-treated
embryos. Genes related to apoptosis are known to be upregulated in
SCNT embryos compared to fertilized embryos (Matoba et al.,
2014), and the TSA(0-8 h)+VC(8-15 h) treatment, but not the
TSA(0-8 h) treatment, downregulates such detrimental genes for
embryonic development in SCNT embryos. In addition, 35
transcripts out of 153 upregulated transcripts (red highlighted in
Table S4) are included in the 141 upregulated transcripts
(Table S1), which were identified as differentially expressed
genes between TSA(0-8 h)+VC(8-15 h) and control SCNT
embryos. Furthermore, 13% of downregulated genes by the TSA
(0-8 h) treatment (blue highlighted in Table S3; 13 out of 97
downregulated genes) were upregulated by the TSA(0-8 h)+VC(8-
15 h). Taken together, the treatment with VC generally upregulates
gene expression, including transcripts that are downregulated by the
TSA treatment.
Upregulated expression of the early-embryo-specific
retroelement in SCNT embryos treated with TSA and VC
We next asked if treatment with TSA(0-8 h)+VC(8-15 h) affects the
expression of retroelements, some of which are highly expressed in
mouse embryos at the two-cell stage, including ERVL (Ishiuchi
et al., 2015; Macfarlan et al., 2012). ERVL is suppressed in
SCNT embryos, compared to IVF embryos (Matoba et al., 2014).
Interestingly, the expression of ERVL was upregulated in the SCNT
embryos treated with TSA(0-8 h)+VC(8-15 h), compared to the
non-treated control SCNT embryos (Fig. 2D). Transcripts from
LINE sequences were also upregulated and expression of other
retroelements was not greatly affected (Fig. S4). These results
suggest that the suppressed expression of the retroelement ERVL in
the SCNT embryos is rescued by the TSA(0-8 h)+VC(8-15 h)
treatment.
Reduced histoneH3K9methylation is associatedwith a high
developmental potential of TSA- and VC-treated SCNT
embryos
We have shown that TSA(0-8 h)+VC(8-15 h) treatment enhances
transcription from H3K9me3-enriched reprogramming-resistant
genes (Fig. 2C). Moreover, VC has been shown to accelerate
epigenetic reprogramming including demethylation of DNA (Zhang
et al., 2016) and histone H3K9 (Chen et al., 2013). We therefore
examined changes in epigenetic modifications in TSA(0-8 h)+VC
(8-15 h)-treated SCNT embryos. The upregulated expression
of Kdm3b, a H3K9 demethylase, was observed in SCNT embryos
after TSA(0-8 h)+VC(8-15 h) treatment (Fig. S5). A reduction in
H3K9me3 was also observed at the two-cell stage after TSA(0-8 h)+
VC(8-15 h) treatment (Fig. 3A). In addition, 5-hydroxymethylation
(5hmC) was increased by TSA(0-8 h)+VC(8-15 h) treatment in
SCNT embryos (Fig. S6) suggesting enhanced TET activities and
DNA demethylation in SCNT embryos. Together, TSA(0-8 h)+VC
(8-15 h) treatment decreases the abnormally high levels of
H3K9me3 and DNA methylation in SCNT embryos, which may
result in successful activation of reprogramming-resistant genes and
the retrotransposons (Fig. 3B).
Table 1. The effect of trichostatin A (TSA) and/or vitamin C (VC) on full-term development of cloned embryos
Treatments
No. of embryos
transferred % live offspring* % IP sites**
Average body weight (g)
(mean±s.d.)
Average placental weight (g)
(mean±s.d.)
NC 178 0 (0)b 3 (1.7)c NA NA
TSA (0-8 h) 124 5 (4.0)b 76 (61.3)a,b 1.51±0.30 0.25±0.05
VC (8-15 h) 125 0 (0)b 56 (44.8)b NA NA
VC (0-24 h) 84 2 (2.4)b 38 (45.2)b 1.58±0.18 0.32±0.04
TSA (0-8 h)+VC (8-15 h) 105 16 (15.2)a 81 (77.1)a 1.43±0.19 0.28±0.07
NC, non-treated control; IP, implantation; NA, not applicable; s.d., standard deviation.
*The proportion of transferred embryos that resulted in live offspring.
**The proportion of transferred embryos that resulted in implantation sites.
a,b,cValues with different superscripts within the same column are significantly different as judged by Fisher’s exact test (P<0.05) (n=4-8).
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DISCUSSION
Somatic cell nuclear transfer offers us a unique opportunity to
experimentally render differentiated cells totipotent, enabling
production of cloned animals from adult somatic cells. However,
the adult somatic cells are resistant to this reprogramming and often
retain somatic chromatin states even in reconstructed cloned
embryos. As a result, SCNT embryos frequently exhibit aberrant
histone modifications and gene expression, compared to normally
fertilized counterparts. Landmark studies have discovered
repeatedly observed abnormalities in SCNT embryos, including
ectopic expression of noncoding RNA Xist (Inoue et al., 2010),
repression of genes in large organized chromatin K9 modifications
(LOCKs) (Fukuda et al., 2010; Inoue et al., 2010), defects in
trophoblast cell lineage (Lin et al., 2011) and downregulated
expression of genes enriched with H3K9me3 (Matoba et al., 2014).
Previous studies have shown that correction of these representative
defects greatly improves birth rates of SCNT embryos up to around
15% (Inoue et al., 2010; Lin et al., 2011; Liu et al., 2016; Matoba
et al., 2014). Themethod we presented here also supports a similarly
high birth rate of SCNTembryos (15.2%, Table 1).We achieved one
of the most efficient mouse clones just by optimizing the culture
condition without genetic manipulation, mRNA injection or help
Fig. 2. RNA-seq analyses identify the reproducibly upregulated transcripts and retroelement in SCNT embryos incubated with TSA and VC in the
medium containing deionized BSA. (A) An experimental scheme for nuclear transfer with TSA and VC treatment, and subsequent RNA-seq analysis.
(B) Hierarchical clustering analysis of the global gene expression profile after SCNT with various different treatments with TSA and/or VC. SCNT embryos
incubated with TSA(0-8 h)+VC(8-15 h) are marked by the red square while those with TSA (0-8 h) are with the blue square. (C) Hypergeometric tests were
performed among the lists of genes that were upregulated by TSA+VC, downregulated in cloned embryos (Matoba et al., 2014) and identified as reprogramming
resistance in cloned embryos (Matoba et al., 2014) and in iPS cells (Soufi et al., 2012). (D) ERVL retroelement was upregulated by the treatment with TSA(0-8 h)+
VC(8-15 h) when compared to the control non-treated SCNT embryos.
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of tetraploid complementation. Thus, our simple method will be
readily applicable to many laboratories and may be useful for
cloning in other species, in which genetic manipulation, RNA
injection and tetraploid complementation are not available.
Synergistic effects of histone deacetylase inhibitors with other
factors to improve cloning efficiency have been explored because
histone deacetylase inhibitors, including TSA, reliably enhance
development of cloned embryos (Ogura et al., 2013). Despite
numerous attempts, striking additive effects have not been observed
(Inoue et al., 2010; Mallol et al., 2015; Matoba et al., 2014), apart
from one of the highest mouse cloning rates to term achieved by the
TSA treatment and siRNA injection against Xist (Matoba et al.,
2011). We here show that sequential treatment of TSA and VC is
key to maximizing their influences on reprogramming (Figs 1C and
2B, Table 1). TSA treatment, which begins right after nuclear
transfer, increases histone acetylation in pronuclei and accelerates
chromatin decondensation and proper organization of constitutive
heterochromatin (Bui et al., 2010; Maalouf et al., 2009), suggesting
that TSA contributes to initial remodeling of injected somatic
nuclei presumably by relaxing chromatin. VC starts to enhance
reprogramming 8 h after the commencement of activation, which
represents approximately the same timing as the initiation of DNA
replication and appearance of DNA repair markers, related to DNA
demethylation (Wossidlo et al., 2010). In addition, this timing
Fig. 3. Reduced histone H3K9 trimethylation in SCNT embryos treated with TSA and VC. (A) Immunostaining analysis indicated that SCNT embryos with
TSA+VC showed a significantly lower level of H3K9me3 compared to control embryos. Different letters indicate statistical significance (P<0.05, one-way ANOVA
with subsequent Tukey’s multiple comparison tests). Fourteen or fifteen two-cell embryos were examined. Error bars represent means±s.e. (n=3). (B) A model
shows how the treatment with trichostatin A and vitamin C in the dBSA-containing medium enhances epigenetic reprogramming and results in the enhanced
cloning success rate.
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coincides with Tet3-mediated accumulation of 5hmC (Amouroux
et al., 2016). Furthermore, demethylation of H3K9me2 can be
induced until 10 h after activation (Wang et al., 2007). These results
suggest that dynamic epigenetic reprogramming was induced in
SCNT embryos when VC was added in our experiments. It is also
noteworthy that the retroelement ERVL is transcribed as early as 8 h
after oocyte activation (Kigami et al., 2003). Therefore, the proper
erasure of somatic epigenetic memories and establishment of
embryonic epigenetic signatures at this stage might be crucial for
subsequent gene activation and hence embryonic development.
In fact, our RNA-seq analyses revealed that both TSA and VC
contribute to rescued gene expression in SCNT embryos at the two-
cell stage, although the mechanism of action seems different
between those two molecules. TSA induces not only activation of a
set of genes but also downregulation of gene expression, while VC
generally supports transcriptional activation including those
downregulated by the TSA treatment.
The effect of TSA and VC was well-exerted when dBSA was
added to mouse embryo culture medium instead of BSA. dBSA has
been used as a component of culture media for human bone marrow
cells (Leary et al., 1990) and for differentiating human ES cells (Ng
et al., 2008). Injection of dBSA into oocyte cytoplasm enhances
development of SCNT embryos while addition of dBSA to culture
medium does not support better development than control (Isaji
et al., 2015). This is in good agreement with our results that only
dBSA did not support efficient development (non-treated control
in Table 1). Nevertheless, the obvious requirement of dBSA for
efficient development was seen when dBSA was used in
combination with TSA and VC (Fig. S2), indicating synergistic
effects of TSA, VC and dBSA. One possible explanation for this
additive effect is that deionization of BSA removes metal ions that
are reactive to VC from culture medium, thus increasing the ratio
of free VC that can work with intracellular iron ion to increase
the activities of Fe2+- and oxoglutarate-dependent enzymes to
accelerate demethylation. Further investigation of dBSA may
offer opportunities to reveal new mechanistic insight into
reprogramming.
A key for efficient reprogramming is to break epigenetic barriers
that stabilize somatic cell states. H3K9me3 has been convincingly
shown as one of such barriers in SCNT embryos (Liu et al., 2016;
Matoba et al., 2014) and in iPS cells (Chen et al., 2013; Soufi et al.,
2012; Sridharan et al., 2013). Our study shows that the H3K9me3
barrier can be at least partially removed just by adding TSA and VC
to the dBSA-containing medium at the appropriate timing (Figs 2C
and 3B). H3K9 demethylation by VC is mediated through the
elevated KDM3/4’s activity in iPS cells, including KDM3B (Chen
et al., 2013). Previous studies showed that the overexpression of
Kdm4b, Kdm4d and Kdm5b enhances the development of mouse
SCNT embryos (Liu et al., 2016; Matoba et al., 2014), while our
TSA(0-8 h)+VC(8-15 h) treatment upregulates Kdm3b expression
(Fig. S5). These results suggest that the improved development
by the TSA(0-8 h)+VC(8-15 h) treatment might be mediated by a
different mechanism from the previously observed effects of histone
demethylase overexpression in SCNT embryos. One functional
difference between Kdm3b and Kdm4b/4d/5b that has been shown
to enhance mouse cloning is that Kdm3b demethylates H3K9me1/2
(Nottke et al., 2009), in good agreement with our observation that
the H3K9me2-regualted retrotransposon MuERVL (Maksakova
et al., 2013) is upregulated in SCNT embryos (Fig. 2D). Therefore,
the improved development by the TSA(0-8 h)+VC(8-15 h)
treatment might be not only through reducing H3K9me3, but also
by downregulating H3K9me1/2. Moreover, hydroxymethylation
was increased by TSA(0-8 h)+VC(8-15 h) treatment in SCNT
embryos (Fig. S6), suggesting enhanced TET activities and DNA
demethylation in SCNT embryos. Importantly, incomplete erasure
of the somatic type of DNA methylation is also regarded as a major
obstacle for successful reprogramming (Mikkelsen et al., 2008).
These results demonstrate that TSA+VC treatment in SCNT
embryos can overcome epigenetic barriers, resulting in the
dramatic improvement of mouse cloning. Although TSA+VC
treatment clearly affects epigenetic changes as mentioned above,
several lines of evidence demonstrate that the development of SCNT
embryos is also influenced by non-epigenetic factors (Miyamoto
et al., 2011; Mizutani et al., 2012). For example, abnormal
chromosome segregation is a major cause of developmental arrest
of cloned embryos (Mizutani et al., 2012), which may in turn result
in abnormal gene expression. Inhibition of class IIb HDACs, whose
targets include not only histones but also chaperones and tubulin,
plays a key role for improved development of cloned embryos (Ono
et al., 2010). Furthermore, two-digit cloning rates can be achieved
by using latrunculin A, an actin polymerization inhibitor, instead of
cytochalasin B (Terashita et al., 2012). It is therefore plausible that
the observed positive effects of TSA+VC treatment in the dBSA-
containing medium might be accomplished by the combination of
epigenetic and non-epigenetic factors, which warrants further
investigation into the contribution of non-epigenetic factors. In
conclusion, our refined protocol for mouse somatic cell nuclear
transfer will ensure the efficient production of cloned mice and will
make the SCNT technique widely available for a variety of
applications, including preservation of genetic materials and
regenerative medicine.
MATERIALS AND METHODS
Animals
B6D2F1 (C57BL/6J×DBA/2N) and ICRmicewere obtained from Japan SLC
(Hamamatsu, Japan) or CLEA Japan (Tokyo, Japan). This study conformed to
the Guide for the Care and Use of Laboratory Animals. All animal
experiments were approved and performed under the guidelines of the Animal
Research Committee, Kyoto University and Kindai University, Japan.
Collection of oocytes and cumulus cells
Female B6D2F1 mice, aged 8-10 weeks, were superovulated by
intraperitoneal injections of 7.5 IU of pregnant mare serum gonadotropin
(PMSG; ASKAAnimal Health, Tokyo, Japan) followed 48 h later by 7.5 IU
of human chorionic gonadotropin (hCG; ASKA Pharmaceutical, Tokyo,
Japan). Cumulus–enclosed oocytes at the second meiotic metaphase (MII)
stage were collected from the oviducts 15 h after the hCG injection in
Hepes-buffered CZBmedium (HCZB) (Chatot et al., 1989) and treated with
0.1% hyaluronidase in HCZB at 37°C until dispersion of cumulus cells.
Cumulus-free oocytes were then washed and kept in drops of 0.3% dBSA
(see below) containing KSOMmedium without EDTA (mKSOM), covered
with mineral oil, at 37°C in air containing 5% CO2 until use. Dispersed
cumulus cells were removed from the hyaluronidase and placed in 6% dBSA
containing HCZB until being used as donor cells for SCNT. For experiments
shown in Fig. 1D, mouse embryonic fibroblast cells were derived from day
11.5 mouse embryos (ICR×ICR).
Preparation of deionized bovine serum albumin
Stock solution of dBSA was prepared as described previously (Isaji et al.,
2015; Ng et al., 2008). Briefly, BSA (Sigma-Aldrich, cat. code: A3311) was
dissolved in distilled water at a concentration of 12%. Approximately
360 mg of mixed ion-exchange resin beads [AG501-X8(D); Bio-Rad] was
then added to 10 ml of 12% BSA solution, and the mixture was incubated at
room temperature with occasional stirring. When the beads changed color
from blue-green to gold, fresh beads were replaced in the BSA solution for a
total of three replacements. The supernatant was sterilized with filtration
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(0.45 µm, Millipore) and stored at −20°C as 12% stock solution. In
mKSOM medium for culturing SCNT embryos, 0.3% BSA was
supplemented. For Fig. S2B, BSA purchased from Calbiochem (San
Diego, CA, USA, cat. code: 126609) was used to compare with the above
mentioned dBSA.
Somatic cell nuclear transfer
SCNT was carried out as described previously (Isaji et al., 2015). Briefly,
enucleation of denuded MII oocytes was performed in drops of HCZB
containing 5 µg/ml cytochalasin B (Sigma-Aldrich). After enucleation, a
donor cell in HCZB with 6% dBSAwas placed in the perivitelline space of
an enucleated oocyte together with HVJ-E (GenomeONE-CF, Ishihara
Sangyo, Osaka, Japan) by tightly attaching the donor cell to the enucleated
oocyte, the oocyte was then cultured in mKSOM for 1 h at 37°C in air
containing 5% CO2, during which time it fused with the donor cell. The
reconstructed oocytes were activated by the incubation for 6 h in 5 mM
SrCl2 and 2 mM EGTA-containing mKSOM supplemented with 5 µg/ml
cytochalasin B, referred to as activation medium (Isaji et al., 2015;
Kishigami and Wakayama, 2007), at 37°C in air containing 5% CO2.
Epigenetic modifier and antioxidant treatments of cloned
embryos
For epigenetic modifier treatments, trichostatin A (TSA, Sigma-Aldrich, cat.
code: T8552) was dissolved in DMSO to prepare 10 µM stock solution and
stored at −20°C. Vitamin C (VC, Sigma-Aldrich, cat. code: A5960) was
dissolved in distilled water to prepare 1 mg/ml stock solution, filtered, and
stored at −20°C. The final concentrations of both epigenetic modifiers were
prepared by diluting the stock solution in activation or mKSOM culture
media, depending on the experimental procedure (Figs 1 and 2A). The
reconstructed oocytes were treated with 50 nM TSA for 8 h from the
commencement of activation (COA), with VC at various concentrations
(1, 10, 25 and 50 µg/ml) for 24 h after COA, with 10 µg/ml VC for 8 or 15 h
after COA, or with 10 µg/ml VC during the period of 8 to 15 h after COA.
The best developmental outcome was obtained by incubating the
reconstructed oocytes with 50 nM TSA for 8 h after COA followed by
treatment of 10 µg/ml VC for 7 h. For antioxidant treatments, N-acetyl-L-
cysteine (NAC, Sigma-Aldrich, cat. code: A7250) and vitamin E (VE,
Sigma-Aldrich, cat. code: T3634) were used. The reconstructed oocytes
were treated with 1 mM NAC or 100 µM VE 8-15 h after COA. The
activated oocytes were cultured at 37°C in air containing 5% CO2 in
mKSOMbefore or after treatments with epigenetic modifiers or antioxidants
until reaching the two-cell or blastocyst stages.
Immunofluorescence staining
Cloned embryos at different developmental stages were fixed in 3.7%
paraformaldehyde in PBS at 4°C overnight. After permeabilization with
0.5% Triton X-100 in PBS for 40 min at room temperature, samples were
blocked in blocking solution (0.05% Tween-20, 1.5% BSA, and 0.5%
sodium azide in PBS) for 1 h at room temperature. For 5meC and 5hmeC,
the samples were treated with 4 M HCl for 10 min and neutralized with
100 mM Tris-HCl (pH 8.5) for 20 min. The samples were then incubated
with primary antibodies at 4°C overnight. The primary antibodies used were
rabbit anti-CDX2 (1:100, BioGenex, Fremont, CA, USA, cat. code: CDX2-
88), mouse anti-trimethyl histone H3K9 (H3K9me3) (1:100, MBL,
Nagoya, Japan, cat. code: MABI0318), mouse anti-5meC (1:200, Active
Motif, Carlsbad, CA, USA, cat. code: 61479) and rabbit anti-5hmeC (1:200,
Active Motif, cat. code: 39769) antibodies. After washing, the samples were
incubated with the secondary antibodies, Alexa Fluor 488-conjugated anti-
rabbit IgG antibody (1:500; Thermo Scientific, Waltham, MA, USA) or
Alexa Fluor 594-conjugated anti-mouse IgG antibody (1:500; Thermo
Scientific) for 1 h at room temperature. After another washing step, the
samples were stained with 10 µg/ml Hoechst 33258 for 10 min and mounted
on slides in 50% glycerol in PBS.
The fluorescence signals of CDX2, H3K9me3 and Hoechst were
observed using a fluorescence microscope (FSX100, Olympus, Tokyo,
Japan) using the same contrast, brightness, and exposure settings. Digital
images of CDX2, H3K9me3 and Hoechst signals were acquired with the
FSX-BSW software (Olympus). Confocal digital images of the fluorescence
signals of 5mC and 5hmC were captured with a confocal laser-scanning
microscope (Carl Zeiss, Germany) using the same contrast, brightness, and
exposure settings. A semi-quantitative analysis of the fluorescence signals
of H3K9me3, 5mC and 5hmC in the nuclei of each group was conducted
using Image J. The total intensity of H3K9me3, 5mC and 5hmC in each
nucleus was measured from five different random regions and the
background value for the cytoplasm was subtracted. This calculated
intensity was multiplied by the nuclear volume (v=4πr3/3) to yield the total
amount of fluorescence for the nucleus (Bui et al., 2010).
Embryo transfer
Pseudopregnant ICR females mated with sterile ICR males were used as
embryo recipients. SCNT embryos that had developed to the two-cell stage
were transferred to the oviducts of the pseudopregnant females at 0.5 days
post-coitus (dpc). Cesarean section and uterine analysis of implantation sites
were performed in all recipients at 19.5 dpc. If available, lactating foster
mothers were used to raise live pups.
Library preparation
Single embryos after the removal of zona pellucida were subjected to RNA
purification using PicoPure RNA extraction kit (Thermo Scientific)
according to the vendor’s instruction. At the final step of RNA extraction,
9 μl of elution buffer was used to extract RNA from the column. Two μl of
RNA out of 9 μl were subjected to Ovation Single Cell RNA-seq System
(NuGEN) for making a library for sequencing. Two steps of PCR
amplification (14 and 12 cycles) were needed to obtain an adequate
amount of DNA for sequencing. The obtained library was quality-checked
by TapeStation (Agilent) and quantified using Qubit (Thermo Scientific).
Sequencing data filtering
Single end 50 bp sequencing was carried out using the Illumina Hiseq2000
system. Fastq files from Illumina sequencing were filtered for low quality
reads (<Q20), and low quality bases were trimmed from the ends of the reads
(<Q20). Adaptors were removed using cutadapt (Martin, 2011). The
sequencing reads were then mapped to the mouse genome (mm9) using
TopHat and UCSC annotation of exon locations in mm9. This annotation
was also used to generate counts of reads covering exonic regions for each
gene, and RPKM values were calculated from these by normalizing to total
counts and transcript length.
RNA-seq analysis
An unsupervised hierarchical clustering of the RPKM values was performed
using hclust in R (using Euclidean distance and Ward agglomeration). To
prepare the count data for differential expression analysis, a filter was
applied requiring genes to have 1 count per million (CPMs) in all three
treatment replicates or in all three controls. Differentially expressed genes
were then identified using edgeR. Gene ontology terms showing over-
representation of genes that were up- or down-regulated after nuclear
transfer were detected using PANTHER (http://www.pantherdb.org/).
Hypergeometric tests were performed to compare the overlap between
upregulated genes in cloned embryos treated with TSA+VC and other
published gene lists (Matoba et al., 2014; Soufi et al., 2012) (GSE59073 and
GSE36570). Genes passing CPM filter in the control versus TSA+VC
comparison were ordered by fold change. The RPKM values for these genes
were z-score normalized across all samples and plotted on a heatmap.
RepeatMasker (http://www.repeatmasker.org/) was used to identify
locations of retroelements in the mm9 genome. These were then used to
prepare counts, CPMs and RPKMs for each retroelement and differential
expression analysis was performed using edgeR (Robinson et al., 2010), all
following the procedure detailed above. Scatterplots of RPKM values for
TSA(0-8 h)+VC(8-15 h) NT and control NT were generated, splitting the
retroelements by subtype.
Statistical analysis
Percentage data were subjected to arcsine transformation before statistical
analyses. Data on in vitro and in vivo embryonic development were analyzed
by one-way ANOVAwith subsequent Tukey’s multiple comparison tests or
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Fisher’s exact test. Comparison of blastocyst cell numbers and fluorescence
intensity were performed by one-way ANOVA with subsequent Tukey’s
multiple comparison tests. A value of P≤0.05 was considered significant.
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Fig. S1. Cloned fetuses and mice resulted from somatic cell nuclear transfer using epigenetic 
modifiers, trichostatin A (TSA) and vitamin C (VC). (A) Each panel (Kyoto, KY or Kindai, OM) 
shows cloned fetuses and their associated placentae in one foster mother, which were produced by the 
serial treatment of TSA and VC (TSA(0-8h)+VC(8-15h)). High birth rates of cloned fetuses were 
observed in both cases (11.0% and 12.5%, respectively). (B) Healthy cloned mice developed from the 
fetuses shown in Fig. S1A (Kindai, OM). 
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Fig. S2. The effect of antioxidants, vitamin E (VE) and N-acetyl-L-cysteine (NAC), and deionized 
BSA (dBSA) on development of cloned embryos. (A) Cloned embryos were treated with or without 
100 µM VE and 1 mM NAC 8-15 hours after nuclear transfer and development to the blastocyst stage 
was judged. Significant improvement by VE or NAC treatment was not observed. Actual numbers of 
embryos developed to blastocysts per 2-cell embryos are indicated above the corresponding graphs. 
(n=4-8) (B) Deionization of BSA improves development of cloned embryos treated with 
TSA(0-8h)+VC(8-15h). The cloned embryos were cultured with dBSA or with non-processed 
commercial BSA (BSA). Actual numbers of embryos developed to blastocysts per 2-cell embryos are 
indicated above the corresponding graphs. P=0.05 (one-way ANOVA with subsequent Tukey’s multiple 
comparison tests). (n=5) (C) Blastocysts produced by dBSA or BSA are shown. Bars represent 100 μm. 
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Fig. S3. RNA-seq analysis of cloned 2-cell embryos treated with TSA and VC. (A) Heatmap analysis 
compares differentially expressed genes among different treatments. SCNT embryos sequentially treated 
with TSA and VC (TSA(0-8h)+VC(8-15h)) are marked with the red square. Genes with high expression 
are indicated as red, while those with low expression are indicated as blue. (B) RNA-seq tracks for 
Hipk1, which represents a gene that was upregulated by TSA(0-8h)+VC(8-15h) treatment, as compared 
to non-treated SCNT embryos. Exons are represented by small boxes. (C) Representative examples of 
GO terms significantly enriched (P<0.01) in genes upregulated and downregulated after 
TSA(0-8h)+VC(8-15h) treatment. 
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Fig. S4. Retroelement expression in cloned 2 cell embryos treated with TSA(0-8h)+VC(8-15h). The 
expression of retroelements analyzed in this study is summarized at the top and each retroelement is 
shown at the bottom. Horizontal lines represent RPKM values of control non-treated SCNT embryos, 
while vertical lines represent those of TSA- and VC-treated SCNT embryos (TSA(0-8h)+VC(8-15h)). 
ERVL expression is indicated in Fig. 2D. 
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Fig. S5. Kdm3b transcripts are upregulated in SCNT embryos treated with TSA(0-8h)+VC(8-15h) 
compared to control non-treated SCNT embryos. RPKM values are shown. Each sample represents a 
biological replicate. The treatment of TSA(0-8h)+VC(8-15h) is depicted in Fig. 2A. 
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Fig. S6. Increased DNA hydroxymethylation and reduced DNA methylation in pronuclei of mouse 
SCNT embryos treated with TSA and VC. DNA methylation and hydroxymethylation were examined 
by immunostaining analysis in pronuclei of mouse SCNT embryos 10 hours after the commencement of 
activation. SCNT embryos were treated with TSA for 8 hours (TSA) and TSA for 8 hours, followed by 2 
hours with VC (TSA+VC). Relative fluorescence intensities of 5’-hydroxymethylated cytosine (5hmC) 
to 5’-methylated cytosine (5mC) were shown. Different letters indicate statistical significance (P<0.05, 
one-way ANOVA with subsequent Tukey’s multiple comparison tests). Error bars represent means ± 
standard errors. Representative immunofluorescent images of 5hmC and 5mC are shown below. 
Between 15 and 20 embryos were examined. Scale bars represent 10 μm. (n=3) 
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Table S1. The list of upregulated or downregulated genes in SCNT embryos 
treated with TSA and VC (TSA(0-8h)+VC(8-15h) vs control). 
 
 
Click here to Download Table S1 
 
 
 
 
Table S2. Genes that overlapped between the genes previously identified as 
reprogramming-resistant and those upregulated by the TSA and VC 
treatment. 
 
 
Click here to Download Table S2 
 
 
 
 
Table S3. The list of upregulated or downregulated genes in SCNT embryos 
treated with TSA (TSA(0-8h) vs control). 
 
 
Click here to Download Table S3 
 
 
 
 
Table S4. The list of upregulated or downregulated genes in SCNT embryos 
treated with TSA and VC (TSA(0-8h)+VC(8-15h) vs TSA(0-8h)). 
 
 
Click here to Download Table S4 
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